Emily Leaf, BCPS, Jerri O. King, Pharm.D.; Patient outcomes after formulary conversion from immediate-release to extended-release glipizide tablets, Americ
No takes yet. Share an insight, caveat, or question.
Leaf et al. (1999) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: